We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$100M
AUM Growth
-$7.81M
Cap. Flow
-$11.3M
Cap. Flow %
-11.27%
Top 10 Hldgs %
11.69%
Holding
238
New
12
Increased
100
Reduced
117
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Healthcare 26.32%
3 Consumer Discretionary 12.34%
4 Industrials 8.94%
5 Financials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNXN icon
76
PC Connection
CNXN
$2.11B
$491K 0.49%
9,224
-2,456
-21% -$116K
PHR icon
77
Phreesia
PHR
$663M
$488K 0.49%
20,411
+1,904
+10% +$47.5K
UI icon
78
Ubiquiti
UI
$33.7B
$488K 0.49%
1,663
-408
-20% -$120K
TWST icon
79
Twist Bioscience
TWST
$5.7B
$487K 0.49%
19,177
+1,132
+6% +$48.1K
XPEL icon
80
XPEL
XPEL
$1.22B
$485K 0.48%
7,591
+823
+12% +$53.4K
ENOV icon
81
Enovis
ENOV
$1.68B
$482K 0.48%
8,788
GRWG icon
82
GrowGeneration
GRWG
$86.5M
$479K 0.48%
74,105
-1,678
-2% -$7.75K
GPK icon
83
Graphic Packaging
GPK
$3.17B
$478K 0.48%
21,449
-5,593
-21% -$123K
TASK icon
84
TaskUs
TASK
$556M
$473K 0.47%
23,064
+3,857
+20% +$68.1K
FIVE icon
85
Five Below
FIVE
$12B
$472K 0.47%
3,235
-271
-8% -$35.6K
EGRX
86
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$465K 0.46%
12,704
+976
+8% +$35.8K
FNV icon
87
Franco-Nevada
FNV
$41.1B
$464K 0.46%
3,565
-279
-7% -$35.1K
EVR icon
88
Evercore
EVR
$12.4B
$462K 0.46%
4,071
+690
+20% +$65.2K
EPAM icon
89
EPAM Systems
EPAM
$5.51B
$461K 0.46%
1,274
-423
-25% -$162K
IEP icon
90
Icahn Enterprises
IEP
$5.24B
$457K 0.46%
9,207
-2,478
-21% -$128K
HSTM icon
91
HealthStream
HSTM
$819M
$456K 0.45%
18,266
-13,300
-42% -$302K
TSLA icon
92
Tesla
TSLA
$1.23T
$453K 0.45%
1,707
-567
-25% -$158K
AGNT
93
AGNT Inc
AGNT
$666M
$440K 0.44%
36,636
+3,144
+9% +$43.8K
EXE
94
Expand Energy Corp
EXE
$21.8B
$436K 0.43%
4,362
+1,998
+85% +$188K
CMG icon
95
Chipotle Mexican Grill
CMG
$47.2B
$427K 0.43%
14,200
-4,100
-22% -$127K
ARVN icon
96
Arvinas
ARVN
$518M
$426K 0.42%
8,039
+705
+10% +$34.2K
FLWS icon
97
1-800-Flowers.com
FLWS
$250M
$424K 0.42%
50,011
-15,893
-24% -$141K
EXEL icon
98
Exelixis
EXEL
$13.3B
$421K 0.42%
25,480
-23,357
-48% -$451K
AMPH icon
99
Amphastar Pharmaceuticals
AMPH
$879M
$416K 0.41%
14,669
+834
+6% +$27.2K
FATE icon
100
Fate Therapeutics
FATE
$286M
$408K 0.41%
20,273
+3,747
+23% +$108K

Similar funds

Capital Impact Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Capital Impact Advisors held 238 positions worth $100M, down 7.2% from $108M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors withdrew a net $11.3M in Q3 2022, closing 1 position and reducing 117 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $772K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Ginkgo Bioworks worth $118K.

  • Capital Impact Advisors's largest Q3 2022 buy was Ginkgo Bioworks: 1,374 shares worth $118K.
  • Capital Impact Advisors added most to Arhaus in Q3 2022, an estimated $228K increase.
  • Capital Impact Advisors's biggest Q3 2022 reduction was e.l.f. Beauty, cutting an estimated $919K.
  • Capital Impact Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $772K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $100M portfolio in Q3 2022.
  • Capital Impact Advisors opened 12 new positions and closed 1 in Q3 2022.
  • Capital Impact Advisors's portfolio value fell 7.2% quarter-over-quarter to $100M.

Based on Capital Impact Advisors's 13F filing for Q3 2022, filed 22 Nov 2022.